Insights

Insights

Latest Insights

Insights

Latest updates, expert perspectives, and success stories—highlighting innovation in viral vector research and biotech.

Tailored Genes Connects with Canada’s Research Community at BioTech Connect
08Jul

Tailored Genes Connects with Canada’s Research Community at BioTech Connect

April 2, 2026 | MaRS Discovery District, Toronto On April 2, the Tailored Genes team…

Tailored Genes at the ASGCT 2026 Annual Meeting
15May

Tailored Genes at the ASGCT 2026 Annual Meeting

ASGCT 2026: Building Connections That Move Gene Therapy Forward Boston, MA | American Society of…

Viral Vector Stability During Long-Term Frozen Storage: What Really Happens to Infectivity
13Feb

Viral Vector Stability During Long-Term Frozen Storage: What Really Happens to Infectivity

When researchers talk about viral vector “stability,” they’re often talking about something deceptively simple: Will…

Canadian Biotech Tailored Genes Secures over $1M Federal Investment to Scale Gene Therapy Production
29Oct

Canadian Biotech Tailored Genes Secures over $1M Federal Investment to Scale Gene Therapy Production

 Toronto, ON, October 21, 2025 The Government of Canada, through the Federal Economic Development Agency…

Innovative Gene Therapy Innovation Finds New Home In Vaughan – To Open 5000 Sq Ft Facility To “Advance Gene Therapy Innovation.”
18Aug

Innovative Gene Therapy Innovation Finds New Home In Vaughan – To Open 5000 Sq Ft Facility To “Advance Gene Therapy Innovation.”

Vaughan, Ontario, Date:21- May-2025 Something big is going on in Vaughan, Ontario. Biotech company Tailored…

Tailored Genes Breaks New Ground to build Full-Service Viral vector Facility in Vaughan
18Aug

Tailored Genes Breaks New Ground to build Full-Service Viral vector Facility in Vaughan

In an era where speed, precision, and innovation are redefining the boundaries of science, Tailored…

Gene therapy for primary immune deficiencies: a Canadian perspective
18Aug

Gene therapy for primary immune deficiencies: a Canadian perspective

Abstract The use of gene therapy (GT) for the treatment of primary immune deficiencies (PID)…

Canada’s Biotech Ecosystem is Thriving: Tailored Genes is Leading the Way
18Aug

Canada’s Biotech Ecosystem is Thriving: Tailored Genes is Leading the Way

The recent announcement of AstraZeneca’s C$820 million investment in Canada is a testament to the…

Canada’s Growing Biomanufacturing Sector: The Critical Role of Viral Vectors
18Aug

Canada’s Growing Biomanufacturing Sector: The Critical Role of Viral Vectors

Canada is rapidly emerging as a global powerhouse in biomanufacturing, with increased investment in research,…

Inbox-worthy insights.

Sign up for the latest Tailored Genes news and updates.

Sign up to get the latest news, insights, and updates from Tailored Genes—delivered straight to your inbox.





    Scroll to Top